Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 55-74
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.55
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.55
Prevalence of H. pylori | Diagnostic tool of H. pylori | Study design | P value | |
Zhou et al[30] | Laryngeal CA: OR: 3.28; 95%CI: 1.91-5.63 | Histochemical, PCR, rapid urease test | Meta-analysis | < 0.0001 |
Pharyngeal CA: OR: 1.35; 95%CI: 0.86-2.12 | = 0.188 | |||
Siupsinskiene et al[31] | Laryngeal CA: Case 46.2% and controls 9.1% | Rapid urease test | Case- control study | < 0.05 |
Zhou et al[32] | Laryngeal CA: OR: 2.3 95%CI: 1.28-3.23 | Serology, histopathological methods | Meta-analysis | < 0.01 |
Pirzadeh et al[34] | Laryngeal CA: Case 49.2% and controls 40% | Rapid urease test | Case- control study | NA |
- Citation: Kuo YC, Yu LY, Wang HY, Chen MJ, Wu MS, Liu CJ, Lin YC, Shih SC, Hu KC. Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum. World J Gastrointest Oncol 2022; 14(1): 55-74
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/55.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.55